noun
post-marketing drug surveillance; pharmacovigilance after market release
A pharmaceutical term for the ongoing process of monitoring and evaluating a drug's safety and efficacy after it has been approved and released to the market. Used in medical and regulatory contexts.
育薬は、市販後の医薬品の安全性を確保するために重要です。
Post-marketing drug surveillance is important for ensuring the safety of pharmaceuticals after they are released.
製薬会社は育薬活動を通じて副作用情報を収集する
Pharmaceutical companies collect adverse event information through post-marketing surveillance activities.
Compound of 育 (いく, 'nurture, raise') and 薬 (やく, 'drug, medicine'), literally 'nurturing a drug'. Coined in Japanese pharmaceutical contexts to describe the concept of continuously monitoring and improving drug safety after market release.